Day: April 7, 2022

Cash and cash equivalents totaled €258.8 million as of December 31, 2021 Major financial achievements in 2021 include landmark strategic partnership deal with Ipsen, successful convertible debt renegotiation and non-dilutive funding through French State-Guaranteed Loans Important R&D milestones reached in 2021, including launch of Phase 1 in acute on chronic liver failure (ACLF), in-licensing of GNS561 (a novel molecule) in cholangiocarcinoma (CCA) and recognition of NIS4® technology’s unique performance by FNIH NIMBLE study Outlook 2022Elafibranor in Primary Biliary Cholangitis (PBC): commitment for topline data readout in the second quarter 2023 reaffirmed NTZ in ACLF: Phase 1 data expected by third quarter 2022 GNS561 in CCA: target to start Phase 1b/2 trial by fourth quarter 2022Conference call (English and French) on April...

FREMONT, Calif., April 07, 2022 (GLOBE NEWSWIRE) — ACM Research, Inc. (ACM) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging (WLP) applications, today announced that COVID-19 related restrictions in Shanghai are impacting employee access to and logistics activities of ACM’s offices and production facilities in the Pudong district of Shanghai, and is therefore limiting ACM’s ability to ship finished products to customers and to produce new products. Spot lockdowns in mid-March began to impact a number of ACM’s employees and led to a closure of ACM’s administrative and R&D offices in Zhangjiang in the Pudong district. A subsequent lockdown of the entire Pudong region of Shanghai was imposed in late March, and has impacted the operation of ACM’s Chuansha production...

Montrouge, 7 april 2022 Crédit Agricole announces the purchase of a 9.18% stake in Banco BPM’s share capital thereby reinforcing its long lasting relationship with Banco BPM S.p.A. Crédit Agricole S.A. (“Crédit Agricole”) announces that – further to purchases on the market and a transaction with a primary financial institution – it has acquired a 9.18% stake in the share capital of the Italian bank Banco BPM S.p.A. (“Banco BPM”). The transaction highlights Crédit Agricole’s very positive appreciation of Banco BPM’s intrinsic qualities: a solid franchise, positive financial perspectives and a strong and performing management team. It also strengthens the solid relationship with Banco BPM, characterized by the long-standing strategic partnership in consumer finance through the joint-venture Agos. Crédit Agricole aims at expanding...

BEDFORD, Mass., April 07, 2022 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its first quarter 2022 financial results after the close of the market on Thursday, May 5, 2022 and hold its investor conference call on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights. The conference call can be accessed by dialing 1-888-254-3590 (toll-free domestic) or 1-856-344-9299 (international) and providing the conference ID number 2795291. A live audio webcast will be available in the Investor Relations section of Anika’s website, www.anika.com. An accompanying slide presentation also can be accessed via the Anika website. The call will be archived and accessible on the...

MONTREAL, April 07, 2022 (GLOBE NEWSWIRE) — TFI International Inc. (NYSE and TSX: TFII), a North American leader in the transportation and logistics industry, today announced that it will hold an Annual and Special Meeting of shareholders on Thursday, April 28, 2022 at 1:30 p.m. (Eastern Time) at the Company’s head office, 8801 Trans-Canada Highway, Suite 500, Saint-Laurent, Quebec. The meeting will also be available by way of telephone conference call. The dial-in number for the meeting is 877-223-4471. Shareholders are asked to participate in the meeting by telephone and to vote their shares prior to the meeting by returning their proxy form or voting instruction form, voting online or using the toll-free telephone number set out on the proxy or voting instruction form. During the telephone meeting, shareholders will be able...

UPPSALA, Sweden, April 07, 2022 (GLOBE NEWSWIRE) — At the Annual General Meeting (the “AGM”) of Olink Holding AB (publ), reg. no 559189–7755, (the “Company”), on 7 April 2022 the AGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the resolutions, please refer to the notice to the AGM and the complete proposals, which have previously been published and are available on the Company’s website, www.olink.com. Adoption of the balance sheet and income statement, disposition regarding the Company’s results and discharge from liabilityThe AGM adopted the Company’s income statement and balance sheet and the consolidated income statement and consolidated balance sheet. The AGM resolved to dispose the Company’s results in accordance with the Board of Directors’ proposal,...

BANNOCKBURN, Ill., April 07, 2022 (GLOBE NEWSWIRE) — Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2022 on Thursday, April 28, 2022 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialing (866) 360-3136 and referencing conference ID 5737323; or via a live audio webcast that will be available online at https://investors.optioncarehealth.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same...

UPPSALA, Sweden, April 07, 2022 (GLOBE NEWSWIRE) — At the Annual General Meeting (the “AGM”) of Olink Holding AB (publ), reg. no 559189-7755, (the “Company”), on 7 April 2022 the AGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the resolutions, please refer to the notice to the AGM and the complete proposals, which have previously been published and are available on the Company’s website, www.olink.com. Adoption of the balance sheet and income statement, disposition regarding the Company’s results and discharge from liabilityThe AGM adopted the Company’s income statement and balance sheet and the consolidated income statement and consolidated balance sheet. The AGM resolved to dispose the Company’s results in accordance with the Board of Directors’ proposal, whereby...

Key Hires Bring Diverse Expertise to Commercial and Development Initiatives MENLO PARK, Calif., April 07, 2022 (GLOBE NEWSWIRE) — Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe endocrine, metabolic, oncologic and neurological disorders by modulating the effects of the hormone cortisol, today announced the appointment of three individuals to Commercial and Development leadership roles. Daniel Einhorn, MD, FACP, FACE, has joined Corcept as Vice President, Endocrine Strategy; Amiel Balagtas has joined as Vice President, Development Operations; and Lyndah Dreiling, MD, has joined as Vice President, Global Oncology Development. Dr. Einhorn will report to Sean Maduck, President of Corcept Endocrinology. Mr. Balagtas and Dr. Dreiling will report...

Completed Seven Investments in New and Existing Portfolio Companies Representing $135 Million in New Commitments and $83.5 Million in Funded Loans Total Loan Commitments and Funded Investments Grow To $1.6 Billion and $1.3 Billion Since InceptionWOODSIDE, Calif., April 07, 2022 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (“Runway Growth”) (Nasdaq: RWAY), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced a portfolio update for the first quarter ended March 31, 2022. “Runway Growth capitalized on its strong momentum in the first quarter, utilizing proceeds from our revolving credit facility to complete seven new investments, strategically increase leverage and drive strong portfolio growth amidst increasing market uncertainty,” said...